First Patients Dosed in Three Trials Assessing Dato-DXd-Based Regimens in Lung Cancer

Opdivo and Yervoy May Improve Survival for Resected Stage 3/4 Melanoma

A Month Without Pink, Almost

Inrebic May Reduce Spleen Volume in Myelofibrosis